Ephaptic crosstalk in Painful Diabetic Neuropathy: an electrodiagnostic study. by Asmedi, Ahmad et al.
173
Ahmad Asmedi et al., Ephaptic crosstalk in painful diabetic neuropathy: an electrodiagnostic study
* corresponding author: aasmedi@yahoo.com
J Med Sci, Volume 50, No. 2, 2018 A ril: 173-179
Ephaptic crosstalk in painful diabetic 
neuropathy: an electrodiagnostic study
Ahmad Asmedi1,2*, Samekto Wibowo2, Lucas Meliala2
1Doctoral Student, Doctoral Programme, Faculty of Medicine Universitas Gadjah Mada, 
2Department of Neurology, Dr. Sardjito General Hospital/Faculty of Medicine, Universitas Gadja 
Mada, Yogyakarta
DOI: http://dx.doi.org/10.19106/JMedSci005002201806
ABSTRACT
Painful Diabetic Neuropathy (PDN) is a common complication of diabetes mellitus 
(DM) which significantly causes pain and distress in patients. Release of factors from 
degenerating fibers activating adjacent fibers to produce ephaptic crosstalk have been 
proposed as one of the pain mechanism in PDN. Here we aim to detect ephaptic crosstalk 
between small fibers and large fibers in PDN subjects by comparing the electrodiagnostic 
result of patients with PDN and patients without PDN.
This study used cohort prospective design. Patients with type 2 DM or impaired 
glucose tolerance (IGT) without PDN from several health facilities in Yogyakarta were 
followed for 12 months for the occurrence of PDN. Demographic, clinical, laboratory and 
electrodiagnostic data from all patients were collected and analyzed. 
One hundred and forty-one subjects (58 men, 83 women) with an average age of 51 
years (range, 40–61 years), were enrolled in this study. After 48 weeks of observation, 
12 subjects were found to have PDN. The differences of distal latency between PDN 
and non-PDN group were significant when measured in median sensory nerve (4.47 ms 
±2.43 versus 3.39 ms ±1.79, p = 0.002), tibial motor nerve (6.96 ms ±3.07 versus 
5.90 ms ±2.17, p = 0.041), and sural sensory nerve (6.02 ms ±3.56 versus 3.55 
ms ±2.90, p <0.001). Among all parameters measured in this study, the H-reflex had 
higher abnormality persentage compared to other electrodiagnostic variable (H latency = 
30%, H amplitude = 71%, H/M Ratio = 88%, and H-M IPL = 15%). 
Our result shows that small fiber neuropathy in PDN can be detected by electrodiagnostic 
study which measures large fibers function. This indicates that ephaptic crosstalk 
between small fiber and large fiber happens in PDN. 
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INTRODUCTION
Painful diabetic neuropathy (PDN) 
and post herpetic neuralgia (PHN) are the 
most frequent painful neuropathies.1 Painful 
diabetic neuropathy significantly causes pain 
and distress in patients with diabetes mellitus 
(DM). Approximately 30% of patients with 
DM develop PDN.2 The pain is typically 
worse at night and characterized by typical 
neuropathic pain descriptors (burning, 
tingling, aching, dysesthesia). Sometimes 
sensory loss can also be found. Over 50% 
of patients report significant problem in 
performing activities of daily living, including 
mobility, work, sleep, recreation and social 
activities.3 This condition can lead to serious 
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psychological problem. Sleep deprivation 
following prolonged periods of intense pain 
can lead to apathy towards life in general, and/
or self-imposed social isolation. Some may 
also experience reduced memory retention, 
mood swings and suicidal tendencies.2
Diabetic neuropathy is characterized 
by progressive distal neurodegeneration. 
This condition adds an additional layer 
of complexity in identifying pathogenic 
mechanisms for neuropathic pain in diabetic 
patients. This nerve degeneration has been 
proposed as a mechanism responsible for 
pain generation in neuropathy.4 Assessment 
of the most distal regions of sensory axons 
have shown the possibility that mechanisms 
by which nerve degeneration may cause 
pain include ectopic activity by destabilized 
degenerating fibers and the release of factors 
from degenerating fibers activating adjacent 
fibers to produce ephaptic crosstalk.4
Ephaptic (electrical) crosstalk has been 
long proposed as a mechanism of neuropathic 
pain. It is a form of fiber-to fiber interaction 
found in neuromas and demyelination 
plaques in nerves and spinal roots.5the 
normal anatomy and physiology of pain; 
second, the pathophysiology of damaged 
sensory neurons; and third, the diagnosis and 
treatment of patients with neuropathic pain. 
The book begins with a discussion of neural 
mechanisms relevant to pain perception 
along with a brief review of neuropathic 
pain. This is followed by separate chapters 
on hyperalgesia following cutaneous injury; 
the importance of peripheral processes in the 
etiology of neuropathic and radiculopathic 
pain; and mechanisms by which sympathetic 
efferent fibers contribute to the occurrence 
of pain. Subsequent chapters cover the 
diagnosis and treatment of reflex sympathetic 
dystrophy; pain in generalized neuropathies; 
surgical treatment of pain; clinical features 
and management of postherpetic neuralgia; 
diagnosis of cancer pain syndromes; and 
drugs in the management of chronic pain. 
Nerve conduction study is commonly used to 
evaluate large myelinated sensory and motor 
nerve fibers, but is ineffective in diagnosing 
small fiber neuropathies.6 In case of PDN 
however, ephaptic crosstalk will result in 
activation of large fibers near the demyelinated 
C fibers. This phenomenon should be able 
to be detected by electrodiagnostic (EDx) 
study. The aim of this study was to detect 
ephaptic crosstalk between small fibers and 
large fibers in PDN subjects by comparing the 
electrodiagnostic result of patients with PDN 
and patients without PDN.
MATERIALS AND METHODS
Subjects
This was an observational study using 
cohort prospective design. The inception 
cohort was diabetes patients free from PDN 
(ID pain score less than 2), followed by a 
12-months disease follow-up. The subjects 
of this study were diabetic patients admitted 
to Diabetes Outpatient Clinic in Dr. Sardjito 
General Hospital, Yogyakarta, members 
of Indonesian Diabetic Association at 
PKU Hospital Yogyakarta, staffs of Health 
Science Academy of Aisiyah, Yogyakarta 
and prediabetic patients involving in the 
research conducted in Department of Clinical 
Pathology, Dr. Sardjito General Hospital, 
Yogyakarta. The protocol of study was 
approved by the Medical and Health Research 
Ethics Committees of Faculty of Medicine, 
Gadjah Mada University. 
Protocol of study
On the appointed day, subjects were 
gathered to be selected. Explanations 
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concerning the background, objective, benefit 
of the study was provided. Subject who meet 
the inclusion and exclusion criteria and were 
willing to involve in the study were provided an 
informed consent to be signed. The inclusion 
criteria were men and women aged 20 to 60 
years old, with type 2 DM or impaired glucose 
tolerance (IGT), as defined by American 
Diabetes Association (ADA) criteria. The 
following were reasons for exclusion: 1) 
anatomical deformities on extremities that 
would interfere with electrodiagnostic study 
protocol; 2) pregnancy or lactation; 3) a 
documented history of lumbosacral surgery 
that would interfere with electrodiagnostic 
study protocol; 4) other diseases known to 
be associated with pain, especially chronic 
pain in the feet that the investigator believed 
would interfere with the assessment of pain 
associated with diabetic neuropathy, like 
cancer pain, lumbosacral abnormality or 
other entrapment neuropathy; 5) any acute 
or underlying serious illness that are likely to 
interfere with completion of the trial.
Clinical and electrodiagnostic examinat-
ions were performed in all patients. Baseline 
assessments, consisted of ID pain, neuropathy 
symptom score (NSS), diabetic neuropathy 
symptom (DNS), review of nerve conduction 
study of upper and lower extremity, and 
soleus H-reflex study, were done at week 1. 
Nerve conduction study and H reflex were 
conducted using an MEB-2300K ENMG 
machine (Nihon Kohden, Tokyo, Japan). The 
evaluation and recording of PDN occurrence 
were carried out every week up to 12 months 
by self-assessment which was monitored by 
the doctors. 
Statistical analysis
Data were presented as mean ± standard 
deviation (SD) or percentage or range. 
Student t test was used to compare between 
PDN and non PDN groups. A p value < 0.05 
was considered as significant. 
RESULTS
One hundred and forty-one subjects (58 
men, 83 women) with an average age of 51 
years (range: 40–61 years), were enrolled 
in this study. The hyperglycemia state were 
diabetic in 65% and IGT in 35% of the 
subjects. The mean glucose level was 116 mg/
dL (range: 78 - 200 mg/dL) for fasting, 170 
mg/dl for 2 h post prandial (range: 90 – 250 
mg/dL). The mean value of HbA1c was 6.9 % 
(range: 4 - 7 %). Screening by NSS and DNS 
scores at admission found that 57 subjects 
(40.4%) were diagnosed as neuropathy (DN) 
according to NSS, while 68 (48.2%) were 
diagnosed as neuropathies according to DNS. 
There were no subjects diagnosed as PDN. 
However, upon completion of 48 weeks of 
observation, 12 subjects were found to have 
PDN.
The electrodiagnostic study showed that 
there were prolonged distal latencies in PDN 
group, while there was no abnormality found 
in non-PDN group (TABLE 1). The differences 
of distal latency between PDN and non-PDN 
group were significant when measured in 
median sensory nerve (4.47 ± 2.43 ms versus 
3.39 ± 1.79 ms, p = 0.002), tibial motor nerve 
(6.96 ± 3.07 ms versus 5.90 ± 2.17 ms, p = 
0.041), and sural sensory nerve (6.02 ± 3.56 
ms versus 3.55 ±2.90 ms, p <0.001). There 
was no significant difference in median motor 
nerve (4.90 ± 0.84 ms versus 4.44 ±1.46 ms, 
p = 0.119).
In the measurement of H-reflex, the 
H-latency prolonged in both groups, but 
significantly longer in PDN group (38.90 ± 
5.94 ms versus 34.82 ± 6.32 ms, p = 0.004). 
The M-latency was also significantly longer 
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(p = 0.003) in PDN group (9.37 ± 3.01 ms) 
compared to non-PDN group (7.51 ± 2.74 
ms). Nerve conduction velocity in PDN 
group decreased significantly compared to the 
non-PDN group (p<0.05). The median nerve 
conduction velocity in PDN group was 44.69 
±10.78 m/s, and 51.51 ±9.08 m/s in non-PDN 
group (p = 0.001). The tibial nerve conduction 
velocity was 33.52 ± 14.86 m/s in PDN group, 
and 41.45 ± 9.64 m/s in non-PDN group (p = 
0.001). 
There were significantly smaller distal 
amplitudes in PDN group compared to non-
PDN group in median motor nerve (3.45 ± 1.82 
mV versus 8.37 ± 6.27 mV, p <0.001), median 
sensory nerve (6.02 ± 10.32 µV versus 14.95 
±15.95 µV, p = 0.008), tibial motor nerve (4.47 
± 3.45 mVversus 7.22 ± 4.47 mV, p = 0.004), 
and sural nerve (4.37 ± 4.16 µV versus 13.89 ± 
14.09 µV, p = 0.001). There was also significant 
difference (p = 0.001) between the H-reflex 
amplitude in PDN group and non-PDN group. 
The H-reflex amplitude was abnormal in PDN 
group (0.29 ± 0.42 mV) while normal in non-
PDN group (1.32 ±1.52 mV).
The PDN group also had significantly 
longer H-M Inter Peak Latency (32.21 ± 6.56 
ms) compared to non-PDN group (27.53 ± 5.87 
ms) (p = 0.0020. The H/M Ratio decreased 
for both groups, but significantly lower (p = 
0.016) in PDN (11.23% ±17.896) compared 
to non-PDN (25.53% ±27.97). Among 
all parameters measured in this study, the 
H-reflex had higher abnormality persentage 
compared to other electrodiagnostic variable 
(H latency = 30%, H amplitude = 71%, H/M 
Ratio = 88%, and H-M IPL = 15%) (Table 2). 
TABLE 1. The analysis of electrodiagnostic parameters value towards PDN status.
Parameter Variable Non-PDN (±SD)
PDN 
(±SD) p CI 95%
Distal Latency Median motor (ms)
Median sensory (ms)
Tibial motor (ms)
Sural sensory (ms)
4.44 (1.46)
3.39 (1.79)
5.90 (2.17)
3.55 (2.90)
4.90(0.84)
4.74 (2.43)
6.96 (3.07)
6.02 (3.56)
0.119 
0.002
0.041
<0.001
-0.12 – 1.08
0.52 – 2.19
0.04 – 2.09
1.15 – 3.79
Nerve Conduction  Median (m/s) 51.51 (9.08) 44.69 (10.78) 0.001 -10.91– -2.72
Velocity Tibial (m/s) 41.45 (9.64) 33.52 (14.86) 0.001 -12.68–3.17
Distal Median motor (mV) 8.37 (6.27) 3.45 (1.82) <0.001 -7.40– -2.40
Amplitude Median sensory (µV)
Tibial motor (mV)
Sural (µV)
14.95 (15.95)
7.22 (4.47)
13.89 (14.09)
6.02 (10.32)
4.47 (3.45)
4.37 (4.16)
0.008
0.004
0.001
-15.50– -2.30
-4.60– -0.87
-15.15– 0. 89
Amplitude H-reflex (mV) 1.32 (1.52) 0.29 (0.42) 0.001 -1.65– -0.42
Latency H-reflex (ms) 34. 82 (6.32) 38.90 (5.94) 0.004 01.35–6.81
M-latency H-reflex (ms) 7.51 (2.74) 9.37 (3.01) 0.003 0.64–3.08
H-M IPL H-reflex (ms) 27.53 (5.87) 32.21 (6.56) 0.002 1.60–6.84
H/M Ratio H-reflex (%) 25.53 (27.97) 11.23(17.896) 0.016 -25.84- -2.73
This table shows that all electrodiagnostic parameters differ significantly between the group with and without 
PDN (p<0.05), except for distal latency of median nerve. PDN= painful diabethic neuropathy.
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TABLE 2. Abnormality percentage of electrodiagnostic variable
Variable Parameter
Result
p Abnormality %Non-PDN PDN
Median (motor)
Amplitude 
D. Latency 
NCV
normal 
normal 
normal
decrease 
prolonged 
slowed
sig.
ns. 
sig.
35 
- 
14
Tibial  (motor)
Amplitude 
D. Latency 
NCV
normal
normal
normal
normal
prolonged
slowed
sig.
sig. 
sig.
0.6 
16 
20
Median  (sensory) Amplitude Latency
normal 
normal
decrease 
prolonged
sig. 
sig. 
50 
35
Sural (sensory) Amplitude Latency
normal 
normal
normal sig. 
sig. 
0 
50
H-reflex
H Latency 
H Amplitude 
H/M ratio 
H-M IPL
prolonged 
normal 
decrease 
normal
prolonged 
decrease 
decrease 
prolonged
sig. 
sig. 
sig. 
sig.
30 
71 
88 
15
This table reveals that, generally, electrodiagnostic parameters in non PDN group are still normal, while 
almost all parameters in PDN group are abnormal. The highest percentage of abnormality was found in the 
decrease of H reflex amplitude (88%). sig= significant ; ns= not significant.
DISCUSSION
The study population in this research was 
patients with abnormality in blood glucose 
level (DM or IGT). The clinical neurological 
complication focused in this study was state of 
being neuropathy with and without PDN. After 
observation for almost 12 months, we found 
around 40% of the subjects with neuropathy 
and 12% with PDN. Electrodiagnostic study 
was performed in all subjects in the initial 
recruitment of this study. Motoric and sensoric 
nerve conduction study and the H reflex study 
were conducted. According to Skljarevski 
& Malik,7 attributes of nerve conduction are 
reliable, reproducible, and objective primary 
outcome measures in trials evaluating 
pharmaceutical treatment of diabetic 
peripheral neuropathy. The principal factors 
affecting nerve conduction velocity (NCV) 
are: the integrity and degree of myelination of 
the largest diameter fibers; the mean axonal 
cross-sectional diameter; the representative 
internodal distance, and the distribution of 
nodal ion channels.7 Our study found that 
almost all EDx variables in non PDN subjects 
were normal. This result indicated that the 
large myelin fibers investigated were intact. 
In healthy peripheral nerves, individual 
myelinated axons form discrete and highly 
isolated conduction channels.5,a stable electrical 
(ephaptic8 Each sensory neuron functions as 
an independent conduction channel until it 
reaches the synapse. In injured nerve, however, 
disruption of glial ensheathment allows adjacent 
denuded axons to make contact, permitting 
both electrical (ephaptic) and chemical (via a 
diffusible substance) cross-excitation.9 This 
phenomenon can be seen in PDN subjects. 
Prolonged latency and decreased amplitudo 
were found in almost all parameters of EDx in 
PDN subjects, except in the latency of median 
motor nerve. Orstavik10 has previously reported 
about altered properties of afferent C-fibres in 
a chronic painful condition. This phenomenon 
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can happen in chronic hyperglycemic subjects. 
Previous researches have shown that ephaptic 
crosstalk can be the source of the pathologic 
pain.11 Acute transection of a neuron has been 
shown to be able to short-circuit neighboring 
axons in a nerve so that the current from the cut 
end of one fiber can excite the others.5,a stable 
electrical (ephaptic8 The same mechanism 
happen in PDN. Electrical impulse running 
through demyelinated axons in PDN can trigger 
demyelinated axons near it to also fire. Ephaptic 
crosstalk between fibers mediating light touch 
(Aβ) and those involved in the generation of 
pain (C and Aδ) may account for the generation 
of pain by light tactile stimulation.12,13
Collateral sprouting from primary 
afferent fibers, which induces ephaptic or 
physical crosstalk between different types of 
fibers, have been proposed to be involved in 
reorganization mechanisms of spinal neuronal 
circuits for pain transmission.13 The damage 
to the nerves can cause regeneration of nerve 
sprouts, called neuromas, at the stump. The 
sprouting of the new nerves in all directions 
causes damage to healthy nerves nearby and 
expands the sensitized area. Hyper excitability 
in the neuroma generates ectopic impulses 
that affect neighboring intact afferents and 
the cell bodies of the dorsal root ganglion.14 
Lysophosphatidic acid (LPA), which is 
released at the dorsal root, demyelinates the 
Aδ- and Aβ-fibers on the dorsal root through 
the LPA1 receptor, followed by physical (or 
ephaptic) crosstalk between the C-fiber and 
Aδ-fiber, and between the Aδ-fiber and Aβ-
fiber.13
Decreased conduction velocity and 
increased activity dependent slowing are 
possible pathological features of a small 
fiber neuropathy like PDN.10,15 Our research 
shows that the processes can also be detected 
by EDx study which assess large fibers. This 
fact supports the idea that ephaptic crosstalk 
between small fibers with large fibers really 
happens in PDN. After ephaptic transmission, 
the action potentials of the two cells were 
conducted at almost the same velocity along the 
axons. The conduction velocity of the action 
potential was reduced from 0.30 ± 0.11 cm/s 
to 0.15±0.05 cm/s by ephaptic transmission of 
the action potential. “container-title”:”Plant 
and Cell Physiology”,”page”:”575-579”,”vo
lume”:”31”,”issue”:”5”,”source”:”pcp.
oxfordjournals.org”,”abstract”:”When two 
separated Chara internodal cells were kept 
in contact over a length of 14 mm or more in 
moist air, an action potential of one cell could 
be transmitted to the other cell in about 40% 
of cases (ephaptic transmission 
CONCLUSION
In conclusion, our result shows that 
small fiber neuropathy in PDN can be 
detected by EDx study which measures large 
fibers function. This indicates that ephaptic 
crosstalk between small fiber and large fiber 
happens in PDN. To our knowledge this is the 
first report of altered properties of afferent C 
fibers in a chronic painful condition captured 
by electrodiagnostic study which actually 
measures the large fibers function.
ACKNOWLEDGEMENTS
We would like to thank dr. Djoko 
Dwijono for helping in statistical analysis, 
dr. Rusdy Ghazali Malueka, PhD. and dr. 
Melania Testudinaria for helping in writing 
the manuscript.
REFERENCES
1. Baron R. Mechanisms of disease: neuropathic 
pain--a clinical perspective. Nat Clin Pract 
Neurol 2006; 2(2):95-106.
 https://doi.org/10.1038/ncpneuro0113
179
Ahmad Asmedi et al., Ephaptic crosstalk in painful diabetic neuropathy: an electrodiagnostic study
2. Kirby M. Painful diabetic neuropathy — 
current understanding and management for 
the primary care team. Br J Diabetes Vasc Dis 
2003; 3:138-44.
 https://doi.org/10.1177/14746514030030021
001
3. Kota SK, Meher LK, Jammula S, Kota SK, 
Modi KD. Diabetic peripheral neuropathy- 
recent trends and future perspectives in 
management. Int J Clin Cases Investig 2012; 
4(2):44-59.
4. Zecuatl TM, Calcutt NA. Biology and 
Pathophysiology of Painful Diabetic 
Neuropathy. In: Lawson E, Misha M 
(eds). Painful Diabetic Polyneuropathy: A 
Comprehensive Guide for Clinicians. New 
York: Springer Science+Business Media, 
2013.
5. Fields HL. Pain Syndromes in Neurology: 
Butterworths International Medical Reviews. 
Butterworth-Heinemann, 1990.
6. Misra UK, Kalita J, Nair PP. Diagnostic 
approach to peripheral neuropathy. Ann 
Indian Acad Neurol 2008; 11(2):89-97.
 https://doi.org/10.4103/0972-2327.41875
7. Skljarevski V, Malik RA. Clinical diagnosis of 
diabetic neuropathy. in: Diabetic neuropathy 
.clinical management. New Jersey: Humana 
Press, 2007.
 https://doi.org/10.1007/978-1-59745-311-
0_16
 https://doi.org/10.1007/978-1-59745-311-
0_1
8. Seltzer Z, Devor M. Ephaptic transmission 
in chronically damaged peripheral nerves. 
Neurology 1979; 29(7):1061-4.
 https://doi.org/10.1212/WNL.29.7.1061
9. Taylor BK. Pathophysiologic mechanisms of 
neuropathic pain. Curr Pain Headache Rep 
2001; 5(2):151-61.
 https://doi.org/10.1007/s11916-001-0083-1
10. Ørstavik K, Namer B, Schmidt R, Schmelz 
M, Hilliges M, Weidner C et al. Abnormal 
function of C-fibers in patients with diabetic 
neuropathy. J Neurosci 2006; 26(44):11287-
94.
 h t t p s : / / d o i . o r g / 1 0 . 1 5 2 3 /
JNEUROSCI.2659-06.2006
11. Hooshmand H. Chronic Pain: Reflex 
Sympathetic Dystrophy, Prevention, and 
Management. CRC Press, 1993.
12. Love S, Coakham HB. Trigeminal neuralgia: 
pathology and pathogenesis. Brain 2001; 
124(Pt 12):2347-60.
 https://doi.org/10.1093/brain/124.12.2347
13. Ueda H. Peripheral mechanisms of neuropathic 
pain – involvement of lysophosphatidic acid 
receptor-mediated demyelination. Mol Pain 
2008; 4:11.
 https://doi.org/10.1186/1744-8069-4-11
14. Aslam A, Singh J, Rajbhandari S. Pathogenesis 
of painful diabetic neuropathy. Pain Res Treat 
2014; 2014:412041.
 https://doi.org/10.1155/2014/412041
15. Tabata T. Ephaptic transmission and 
conduction velocity of an action potential in 
Chara internodal cells placed in parallel and 
in contact with one another. Plant Cell Physiol 
1990; 31: 575–579.
